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SHORT COMMUNICATION
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ABSTRACT
Oxalis pes-caprae L. is a plant of the Oxalidaceae family, from
which several compounds have been previously identified.
Recently, we showed that an Oxalis pes-caprae L. extract inhibits
the vasopressor effect of noradrenaline. In this work we aimed to
explore the mechanisms involved in this effect. The results con-
firmed that the flavonoid fraction present in the extract inhibits
noradrenaline-induced contractions and that this effect is concen-
tration-dependent. Also, a parallel shift to the right in the
noradrenaline concentration-response curve was observed, sug-
gesting a decrease in efficacy and also in potency. Together these
results support the assumption that the extract could exert a
non-competitive antagonism on the a-adrenergic receptors.
However, experiments in the presence of competitive antagonists
for a-adrenergic receptor sub-types (i.e. prazosin, yohimbine and
phentolamine) showed that the effect may not be directly medi-
ated by a-adrenergic receptors. Thus, the interaction of this
extract with the adrenergic system remains to be confirmed.
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1. Introduction
Our group has previously characterized the polyphenolic content of an aqueous leaf
extract of Oxalis pes-caprae L. and evaluated its vascular activity and potential
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antioxidant, anti-inflammatory and neuroprotective properties (Gaspar et al. 2018). In
that study, we showed that the extract exhibited antioxidant activity and significantly
affected the contractile response to noradrenaline. In the present study, we focused
on the vascular effects of the leaf extract of Oxalis pes-caprae L.
Oxalis pes-caprae L. is an invasive weed abundant in Mediterranean zones
(DellaGreca et al. 2007; Ferrero et al. 2015) from which several compounds have been
previously identified by DellaGreca et al. (2007, 2009, 2010, 2008), such as cinnamate
derivatives, aromatic compounds and phenols. In our previous study we also identified
luteolin and apigenin derivatives in the leaves of this plant (Gaspar et al. 2018).
The leaves of Oxalis pes-caprae L. have been used in the traditional medicine for
their antihypertensive effects while its roots to their diuretic activity (Aprilita et al.
2013; G€uçl€ut€urk et al. 2012), thus suggesting a potential use of these bioactive com-
pounds in the context of cardiovascular disease. Accordingly, we recently showed that
the leaf flavonoid extract of Oxalis pes-caprae L. inhibits the contractile response of
the human internal thoracic artery (HITA, also known as internal mammary artery) to
noradrenaline (Gaspar et al. 2018). In this work we aimed to determine whether this
inhibition is concentration-dependent and to assess the potential involvement of
specific sub-types of a-adrenergic receptors in these effects.
2. Results and discussion
2.1. Inhibition of contractile response is concentration-dependent
The leaf extract of Oxalis pes-caprae L. did not induce vasoconstriction (results not
shown), which confirmed our previous results (Gaspar et al. 2018). The increasing con-
centration of extract produced a concentration-dependent inhibitory effect on the
contractile response to noradrenaline (Figure S1). As seen in Table S1, the decrease in
maximal contraction (significant for the 5.2 and 10.4mg/mL concentrations – 85.91%
and 87.76%, respectively) was accompanied by a parallel shift of the noradrenaline
cumulative concentration-response curve to the right, thus indicating a decrease in
potency which was also significant for the 5.2 and 10.4mg/mL concentrations.
Together these results suggested that the extract could exert a concentration-depend-
ent non-competitive antagonism on the adrenergic receptors. Such results are in
agreement with previous studies that showed inhibitory effects of flavonoids (such as
luteolin and homoorientin) on the contractile response in rat isolated thoracic aorta
(Woodman et al. 2005).
Furthermore, other studies have shown the vasodilatory potential of flavonoids
such as luteolin and apigenin (Abdalla et al. 1994; Duarte et al. 1993). Several mecha-
nisms have been implicated in this vasodilatory effect, namely: (a) decreased calcium
uptake in vascular smooth muscle cells (Abdalla et al. 1994; Shoshan et al. 1980), (b)
inhibitory effect on cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP) phosphodiesterase (Laekeman et al. 1986) or (c) protein kin-
ase C activity (Duarte et al. 1993). In the case of apigenin, the vasodilation effect
appears to be partially related to increased levels of cGMP, whereas luteolin may have
a cAMP-mediated inhibitory effect on noradrenaline-induced contractions (Scuro et al.
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2004; Shoshan et al. 1980). Moreover, mechanical removal of the endothelium did not
modify the flavonoid vasodilatory properties (Shoshan et al. 1980).
Studies with orientin from bamboo leaves (Phyllostachys nigra), in rings of thoracic
aortas isolated from New Zealand rabbits, suggest that this flavonoid may produce
vasodilation in pre-contracted rings via the nitric oxide-cGMP pathway in the vascular
smooth muscle. Furthermore, mechanisms involving potassium channels, b-adrenergic
receptors and cAMP do not appear to be involved in these effects (Fu et al. 2005).
2.2. Vascular effect may not be directly mediated by a-adrenergic receptors
The second aim of this study was to evaluate the potential involvement of specific
sub-types of a-adrenergic receptors in the vascular effects of the leaf extract of Oxalis
pes-caprae L. To this purpose, we performed cumulative concentration-response curves
to noradrenaline in the presence of the higher concentration of extract (i.e. 10.4mg/
mL) and several antagonists for a-adrenergic receptors, specifically prazosin (competi-
tive antagonist selective for a1-adrenergic receptors), yohimbine (competitive antagon-
ist selective for a2-adrenergic receptors) and phentolamine (non-selective competitive
antagonist). As shown in Figure S2, the contractile response induced by noradrenaline
was mediated by both receptor sub-types, with a higher contribution from the a2 sub-
type (a higher significant decrease in maximal contraction was seen with prazosin –
87.57% of control). These results are somehow contradictory to previous studies which
showed a higher contribution of the a1-adrenergic receptors in the contractile
response of the HITA to noradrenaline (Giessler et al. 2002; Pesic et al. 2003).
Nevertheless, the a2-adrenergic receptors have been previously implicated in the con-
tractile response of other vessel grafts such as the saphenous vein to noradrenaline
(Giessler et al. 2002).
Interestingly, the extract of Oxalis pes-caprae L did not inhibit the contractile
response to noradrenaline in the presence of the three receptor antagonists (Figure S2
and Table S2). Therefore, the flavonoid fraction present in the extract of Oxalis pes-
capre L. used in this study does not seem to have affinity for both a1 and a2 adrener-
gic receptors. Since there was no direct effect on a-adrenergic receptors, the inhibition
of noradrenaline contraction could be mediated by b-type receptors, thus further
experiments should be performed to evaluate the potential involvement of
such receptors.
3. Conclusions
This study confirmed an inhibitory effect of the flavonoid fraction of the leaf extract of
Oxalis pes-caprae L. on the noradrenaline-induced vasoconstriction. Furthermore, our
study showed that this inhibitory effect is concentration-dependent and may not be
directly mediated by a-adrenergic receptors. Further studies are required to establish a
structure-activity relationship of the compounds present in this flavonoid extract,
to evaluate the potential involvement of b-adrenergic receptors and to assess the
vasodilatory potential of this extract.
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